Cargando…
Celastrol Attenuates Lipid Accumulation and Stemness of Clear Cell Renal Cell Carcinoma via CAV-1/LOX-1 Pathway
Clear cell renal cell carcinoma (ccRCC) is characterized by abnormal lipid accumulation. Celastrol is a pentacyclic triterpene extracted from Tripterygium wilfordii Hook F with anti-cancer activity. In the present study, the anticancer effects of celastrol on ccRCC and the underlying mechanisms were...
Autores principales: | Zhang, Chan-Juan, Zhu, Neng, Wang, Yu-Xiang, Liu, Le-Ping, Zhao, Tan-Jun, Wu, Hong-Tao, Liao, Duan-Fang, Qin, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085775/ https://www.ncbi.nlm.nih.gov/pubmed/33935779 http://dx.doi.org/10.3389/fphar.2021.658092 |
Ejemplares similares
-
Celastrol Prevents Atherosclerosis via Inhibiting LOX-1 and Oxidative Stress
por: Gu, Lei, et al.
Publicado: (2013) -
Celastrol Attenuates Multiple Sclerosis and Optic Neuritis in an Experimental Autoimmune Encephalomyelitis Model
por: Yang, Hongbin, et al.
Publicado: (2017) -
Yue-bi-tang attenuates adriamycin-induced nephropathy edema through decreasing renal microvascular permeability via inhibition of the Cav-1/ eNOS pathway
por: Li, Tingting, et al.
Publicado: (2023) -
Nanotechnology-Based Celastrol Formulations and Their Therapeutic Applications
por: Wagh, Pushkaraj Rajendra, et al.
Publicado: (2021) -
The therapeutic potential of triptolide and celastrol in neurological diseases
por: Cui, Yueran, et al.
Publicado: (2022)